Quotient Mar 25, 2022 In Brief This Week: Siemens Healthineers, Cue Health, Hologic, Theradiag, Quotient, and More Mar 8, 2022 Quotient Limited Nabs CE Mark for Immunohematology Microarray Feb 8, 2022 Quotient Limited Posts 16 Percent Rise in Fiscal Q3 Revenues Jan 3, 2022 360Dx Index Grows 4 Percent in December Alongside Broader Markets Nov 1, 2021 Broader Markets Lift 360Dx Index 3 Percent in October Oct 1, 2021 Broader Markets Weigh Down Dx Stocks, 360Dx Index Falls 4 Percent in September Aug 6, 2021 In Brief This Week: Meridian Bioscience, Veracyte, Amazon, Paige, Quotient, and More Jul 9, 2021 Quotient Launching Multimodal, Multiplex Microarray for Transfusion Diagnostics Premium Jul 1, 2021 360Dx Index Up 7 Percent in June, Rebounding From May Downturn Jun 1, 2021 Quotient Limited Fiscal Q4 Revenues Rise 10 Percent on Reagent Sales Jun 1, 2021 May Lag for Many Dx Firms' Stock Prices as 360Dx Index Drops 4 Percent May 24, 2021 Quotient Limited to Sell $95M of Senior Notes in Private Offering Mar 1, 2021 360Dx Index Declines 4 Percent in February, Ending Streak of Gains Feb 1, 2021 Quotient Limited Fiscal Q3 Revenues Rise 11 Percent Jan 4, 2021 Castle Bio, NantHealth Pace Gainers as 360Dx Index Climbs 4 Percent in December Dec 10, 2020 In Brief This Week: Quotient Limited, Bio-Rad, Danaher, and More Dec 1, 2020 Veracyte, Quotient Limited Lead Gainers as 360Dx Index Inches Up 1 Percent in November Nov 2, 2020 Quotient Limited Fiscal Q2 Revenues Double on Higher Reagent Sales, Distribution Partner Payment Breaking News Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis In Brief This Week: Abbott, Danaher, Lucira Health, Novacyt Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug Quest Diagnostics Enters Lab Deal With Maine Healthcare System Northern Light Health Roche Alzheimer's Disease Assays Obtain FDA 510(k) Clearance Diazyme Gets FDA Emergency Use Authorization for SARS-CoV-2 Antibody Test
